COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • February 26th, 2018 • BioXcel Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 26th, 2018 Company Industry JurisdictionTHIS COLLABORATIVE RESEARCH AGREEMENT (this “Agreement”) is made and entered into as of August 27th, 2017 (“Effective Date”) between BIOXCEL THERAPEUTICS, INC., a Delaware corporation, having its principal place of business at 780 East Main Street, Branford, CT 06405 (“BTI”) and NEKTAR THERAPEUTICS, a Delaware corporation, having its principal place of business at 455 Mission Bay Boulevard South, San Francisco, CA 94158 (“Nektar”). Each of Nektar and BTI may be referred to herein as a “Party” or collectively as the “Parties.”
Strategic Advisor AGREEMENTStrategic Advisor Agreement • February 26th, 2018 • BioXcel Therapeutics, Inc. • Pharmaceutical preparations • Connecticut
Contract Type FiledFebruary 26th, 2018 Company Industry JurisdictionThis Strategic Advisor Agreement (this “Agreement”) between Vince O’Neill having a mailing address at 125 Redbud Trl, West lake Hills TX 78746 (the “Strategic Advisor”), and BioXcel Therapeutics, Inc., a Delaware corporation having a principal place of business at 780 East Main Street, Branford, Connecticut 06405 (the “Company”), is made effective as of July 10th, 2017 (the “Effective Date”). In connection with the appointment of the Strategic Advisor to the Company and the mutual promises of the parties hereunder, it is agreed as follows:
BioXcel Therapeutics Inc. FIRST AMENDMENT TO STRATEGIC ADVISOR AGREEMENTStrategic Advisor Agreement • February 26th, 2018 • BioXcel Therapeutics, Inc. • Pharmaceutical preparations • Connecticut
Contract Type FiledFebruary 26th, 2018 Company Industry JurisdictionThis AMENDMENT (the “Amendment”) to the Strategic Advisor Agreement (the “Agreement”), dated July 10, 2017, by and between BioXcel Therapeutics Inc, a Delaware corporation having a principal place of business at 780 East Main Street, Branford, Connecticut (the “Company”) and Vince O’Neil (the “Strategic Advisor”) is dated as of January 22, 2018 (the “Amendment Effective Date”). Capitalized terms not defined herein shall have the meanings assigned to them in the Agreement.